bi_german_building_at_night

Boehringer expands manufacturing facility in Shanghai

pharmafile | January 22, 2019 | News story | Manufacturing and Production Boehringer Ingelheim, China, Shanghai, facilities, manufacturing, pharma 

German firm Boehringer Ingelheim has expanded the capacity of its commercial manufacturing site for biologics in Shanghai, China.

The expansion will see the installation of an additional bioreactor into the company’s OASIS Shanghai facility.

“We are fully committed to our biopharmaceutical contract manufacturing business in China and it is our utmost goal to serve our customers and their patients with high quality medicines in China and in the global market’, said Prof Buecheler, Head of Biopharmaceutical Business Unit at Boehringer Ingelheim.

Advertisement

Manufacturing processes are scheduled to begin in 2019. A client’s monoclonal antibody will be the first commercial drug manufactured in the Shanghai facility.

“We look forward to providing our customers with this new source of commercial supply of therapeutic antibodies for their patients,”  Dr. Jiali Luo, General Manager and Site Head of Boehringer Ingelheim Bio China said. “Additionally, we see a growing demand for world-class manufacturing capacities of biologics and are eager to offer our capabilities to local and global customers according to our site supply mission ‘China-for-China’ and ‘China-for-Global’.”

Louis Goss

Related Content

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis

Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a …

CARBOGEN AMCIS manufacturing license advances services in China

Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has …

The Gateway to Local Adoption Series

Latest content